Evanston Advisors’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
$3.21M Buy
103,798
+1,347
+1% +$49.1K 0.87% 33
2018
Q3
$3.88M Sell
102,451
-172
-0.2% -$6.51K 0.85% 41
2018
Q2
$3.94M Buy
102,623
+9,058
+10% +$305K 0.89% 40
2018
Q1
$3.15M Buy
+93,565
New +$3.59M 0.73% 46

Other funds holding PBH

Evanston Advisors's PBH Position: Q4 2018 in Review

Evanston Advisors increased its Prestige Consumer Healthcare (PBH) stake by 1.3% in Q4 2018, buying an estimated $49.1K and bringing the position to 103,798 shares worth $3.21M. The position accounts for 0.87% of the portfolio, ranked #33.

Evanston Advisors first reported a position in PBH in Q1 2018 and has held it in 4 quarters since. The position peaked at $3.94M in Q2 2018. 241 funds tracked by Wall St. Rank hold PBH as of Q4 2018.

  • Evanston Advisors held 103,798 shares of Prestige Consumer Healthcare worth $3.21M as of Q4 2018.
  • Evanston Advisors bought 1,347 Prestige Consumer Healthcare shares in Q4 2018, an estimated $49.1K.
  • Prestige Consumer Healthcare made up 0.87% of Evanston Advisors's portfolio in Q4 2018, its #33 holding.
  • Evanston Advisors first reported a position in Prestige Consumer Healthcare in Q1 2018 and has held it in 4 quarters since.
  • Evanston Advisors's Prestige Consumer Healthcare position peaked at $3.94M in Q2 2018.
  • 241 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q4 2018.

Based on Evanston Advisors's 13F filing for Q4 2018, filed 11 Feb 2019.